Biotech startup inks $30M deal to fuel China expansion
July 31, 2019 at 13:03 PM EDT
MediBeacon Inc., a St. Louis-based biotech developer, has reached a $30 million deal giving China's Huadong Medicine Co. Ltd. exclusive rights to MediBeacon's portfolio in China, Hong Kong, Macau and Taiwan.